Advanced Integrative Medical Science Institute, Pllc v. United States Drug Enforcement Admin

Good Law
128 F.4th 1133
United States Court of Appeals for the Ninth CircuitFebruary 13, 202522-1568California7,096 words

Opinion

Opinion

BERZON, J.

FOR PUBLICATION

UNITED STATES COURT OF APPEALS

FOR THE NINTH CIRCUIT

ADVANCED INTEGRATIVE No. 22-1568

MEDICAL SCIENCE INSTITUTE,

Drug Enforcement PLLC; Doctor SUNIL Administration AGGARWAL, MD, PhD, FAAPMR,

FAAHPM; MICHAL OPINION

BLOOM; ERINN

BALDESCHWILER,

Petitioners, v.

UNITED STATES DRUG

ENFORCEMENT

ADMINISTRATION,

Respondent.

On Petition for Review of an Order of the Drug Enforcement Administration Argued and Submitted August 19, 2024 San Francisco, California Filed February 13, 2025 Before: Marsha S. Berzon, Daniel A. Bress, and Lawrence VanDyke, Circuit Judges.

Opinion by Judge Berzon SUMMARY *

Controlled Substances Act

The panel denied a petition for review brought by the Advanced Integrative Medical Science Institute (AIMS) challenging the decision of the Drug Enforcement Administration (DEA) not to exempt AIMS co-director Dr. Sunil Aggarwal from registration under the Controlled Substances Act (CSA) when he sought to provide patients with psilocybin. AIMS asked DEA to exempt Dr. Aggarwal from registration under the CSA, either by finding that Dr. Aggarwal’s proposed use of…

Sign in to read the full opinion

Create a free account to read the complete opinion text, citation history, and good-law status for this case.